Veopoz
Payments companies reported to CMS as associated with Veopoz. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Veopoz, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Veopoz
These are the largest totals companies reported as associated with Veopoz. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Charles Wykoff | Bellaire, TX | Ophthalmology | $6,630.00 |
| Karl Csaky | Dallas, TX | Ophthalmology | $6,610.50 |
| James Howard | Chapel Hill, NC | Neurology (Psychiatry & Neurology) | $6,518.00 |
| Justis Ehlers | Cleveland, OH | Ophthalmology | $5,640.00 |
| Jennifer Lim | Chicago, IL | Ophthalmology | $4,700.00 |
| Jaclyn Kovach | Miami, FL | Ophthalmology | $3,384.00 |
| Shruti Raja | Durham, NC | Neuromuscular Medicine (Psychiatry & Neurology) | $2,050.00 |
| Tuan Vu | Tampa, FL | Neurology (Psychiatry & Neurology) | $1,929.00 |
| Eleonora Lad | Durham, NC | Retina Specialist | $1,880.00 |
| David Dingli | Rochester, MN | Hematology (Internal Medicine) | $1,854.00 |
Prescribed Veopoz?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.